Three iconic brands that lost their shine
Many famous brands have lasted for decades, but history shows that they can suddenly fade away.
Because many consumer brands have been around for 100 years or more, it is easy to assume that they are immortal, churning out cash for their owners through thick and thin. But this is not the case. We are all prone to survivorship bias: the human tendency to forget what has disappeared from view. Brands that are eclipsed by something better, or disappear due to regulation or people’s changing preferences, may linger as a nostalgic memory, but their phenomenal success is forgotten.
How do you define a brand? A popular definition is a product, service or concept that is distinguished from competitors in the minds of consumers by its name, qualities and reputation. This implies that it can command a premium price. Many businesses, such as shops, airlines and cars, achieve brand recognition but struggle on that last test or, as in the case of petrol stations, fail completely.
Companies spend huge amounts of money trying to create new brands, but once the initial marketing blitz ends, sales often drop off. The new brand may stagger on for a while, but it then dies. Successful brands require long-term advertising and marketing support that is carefully pitched to sustain the price point, innovation in packaging and an understanding of the changing preferences of customers.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The recent problems at Diageo and LMVH show that it is easy to overestimate brands’ pricing power. The willingness of customers to pay up for premium drinks labels has faded, yet cutting prices may devalue the brand. Drinkers have other priorities for spending money amid the post-Covid squeeze on their wallets. No doubt these brands will recover, but some that were once huge never have.
The death of Marlboro Man
Marlboro was the most famous of the many cigarette brands, which were killed off as advertising, sports sponsorship and other forms of marketing were banned by governments around the world.
The Marlboro brand was created by Philip Morris in the 1920s as a woman’s cigarette but was repositioned in the 1950s using the image of the “Marlboro Man”, a cowboy complete with a Texan hat. This gave a rugged, outdoors male image while the addition of a filter to the cigarettes, once regarded as effeminate, was supposed to make cigarettes safer to smoke.
Supported by heavy advertising, sales quadrupled in two years and Marlboro quickly became the world’s most popular cigarette. Other cigarette companies resorted to undermining it by seeking a ban on its advertising. The death from lung cancer of a succession of actors who had featured as the face of the “Marlboro Man” did nothing for the brand’s image. Marlboro still sells 240 billion units a year and is the top-selling cigarette worldwide, but the value of sales has fallen by a third since 2015, and the latest country to ban its advertising was Indonesia in 2012.
Bye-bye Babycham
Bambi’s favourite tipple, Babycham, is a sparkling perry developed by drinks company Showerings in the early 1950s. Initially, sales were disappointing but when its price was quadrupled to four shillings a bottle, they took off.
It was marketed as a “Champagne perry” (pear cider) with a trademark “Bambi” deer and was the first alcoholic drink to be marketed on television. Its appeal was as a sophisticated brand for young women to drink in the pub. Their mums drank port and lemon, or Guinness.
Sales peaked in the 1970s at 144 million bottles a year. In 1978, the Champagne houses sued to stop the use of their trade name. Although they were unsuccessful, Babycham stopped calling itself a Champagne. Sales declined and attempts to revive it were only temporarily successful as its target market switched to wine and other cheaper alternatives. Showerings floated on the stockmarket in 1960 and was bought by Allied Lyons in 1968, but the Showering family bought the brand back in 2021 from an intermediate owner. Let’s see how successful they are.
Blackberry: The first smartphone
Mobile phones first appeared in the 1980s as large, clunky brick-like devices, but the phones soon got smaller and their battery lives increased. Nokia came to dominate the European market with its handy pocket-sized phones, but fiddly texting was the only service other than the capacity to make phone calls.
The first BlackBerry smartphone appeared in the late 1990s and took the market by storm, being able to send and receive emails. It worked on several different wireless networks, offered security and used its own servers. Before Wi-Fi became widely available, at a time when bandwidth was also in short supply, customers enjoyed the ability to read messages and delete emails without downloading the text. Companies liked the control it gave them over corporate usage.
At its peak in 2011, BlackBerry had 85 million users. But then Android and Apple arrived, which cut the ground from under BlackBerry’s feet as they offered better technology, while mobile networks were also developing rapidly. By 2016, BlackBerry was down to 21 million users. Some traders still reminisce nostalgically about their BlackBerries, but none would swap their iPhones for one now. The lesson for investors is that brands have tremendous longevity if carefully nurtured, but they do not necessarily last forever.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Read more
- Marlboro Man stubs it out
- The future of vaping – the "healthier cigarette"
- Building a powerhouse beauty brand
- Money makers: a brand for every occasion
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
Number of ISA millionaires triples in three years
The number of people with £1 million in their ISAs has tripled in three years to reach 3,180. But could next week’s Budget put an end to future ISA millionaires?
By Ruth Emery Published
-
IMF upgrades UK growth forecasts ahead of Budget - here is what it means
The upgrade comes ahead of chancellor Rachel Reeves's first Budget on 30 October, where she intends to explain how she will further boost UK economic growth
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published